Supplementary Table 5 presents data on anesthetic induction, maintenance, and pharmacological conditioning. Supplementary Table 6 details patient characteristics, including ASA classification, age, operative time, ischemia duration, presence of cirrhosis, baseline levels of AST, ALT, and bilirubin, surgical indication, and the extent of hepatectomy. This evidence concerns the gene GPT and Cirrhosis.